文献速递腹部MR

钆塞酸增强MRI上表现为肝胆期低信号的富血供原发性肝脏肿瘤的鉴别诊断

Differentiation of hypervascular primary hepatic tumors showing hepatobiliary hypointensity on gadoxetic acid-enhanced magnetic resonance imaging.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

本研究纳入148例经病理证实的富血供肝脏肿瘤患者(23例不典型FNH、11例HCA、15例NET、25例ICC、74例HCC),分析钆塞酸增强MRI形态学、信号强度及强化方式,采用多变量logistic回归确定鉴别特征。结果显示肝胆期反向靶征(FNH)、ADC等或高信号(FNH和HCA)、动脉期中心低信号(NET)、肝胆期靶征(ICC)、存在分隔和包膜(HCC)为独立鉴别特征;两位观察者诊断准确率分别为FNH 98-98.6%、HCA 96.6-98%、NET 97.3-98.6%、ICC 90.5-94.6%、HCC 85.8-93.2%。作者认为这些辅助MRI特征有助于鉴别富血供且肝胆期低信号的原发性肝脏肿瘤。

要点

  • 肝胆期反向靶征提示FNH,肝胆期靶征提示ICC。
  • ADC等或高信号提示FNH或HCA,动脉期中心低信号提示NET。
  • 存在分隔和包膜提示HCC,两位观察者诊断HCC准确率85.8-93.2%。

核心结论

  • 作者认为本研究所建立的辅助MRI特征有助于鉴别钆塞酸增强MRI上富血供且肝胆期低信号的原发性肝脏肿瘤。

研究设计与样本

  • 回顾性纳入148例经病理证实的富血供肝脏肿瘤患者,均行钆塞酸增强MRI,肿瘤包括23例不典型FNH、11例HCA、15例NET、25例ICC和74例HCC;采用多变量logistic回归分析确定鉴别特征,并由两位观察者评估MRI特征的诊断效能。

关键影像表现/征象

  • FNH组出现肝胆期反向靶征(p=0.009)。
  • FNH组和HCA组出现ADC图等或高信号(p=0.009和p<0.001)。
  • NET组出现动脉期中心低信号(p=0.001)。
  • ICC组出现肝胆期靶征(p=0.002)。
  • HCC组出现分隔和包膜(均p<0.001)。

诊断标准与关键数值

  • 两位观察者诊断准确率:FNH为98-98.6%,HCA为96.6-98%,NET为97.3-98.6%,ICC为90.5-94.6%,HCC为85.8-93.2%。

临床应用与阅片要点

  • 阅片时可关注肝胆期反向靶征用于提示FNH、肝胆期靶征用于提示ICC。
  • ADC图等或高信号可提示FNH或HCA,动脉期中心低信号可提示NET。
  • 发现分隔和包膜时可提示HCC。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To determine the imaging features that help differentiate hypervascular primary hepatic tumors showing hepatobiliary hypointensity on gadoxetic acid MRI.

METHODS: This study comprised 148 patients with pathologically proven hypervascular hepatic tumors who underwent gadoxetic acid MRI. Tumors included 23 atypical focal nodular hyperplasias (FNHs), 11 hepatocellular adenomas (HCAs), 15 neuroendocrine tumors (NETs), 25 intrahepatic cholangiocarcinomas (ICCs), and 74 hepatocellular carcinomas (HCCs). MRIs were analyzed for morphologic features, signal intensity, and enhancement pattern of the tumors to determine the differential features using multivariate logistic regression analysis. We evaluated the diagnostic performance of the MRI features for differentiating the five tumor types upon review by two observers.

RESULTS: Multivariate analysis revealed that reverse target sign on hepatobiliary phase in FNHs (p = 0.009), iso or hyperintensity on ADC map in FNHs and HCAs (p = 0.009, < 0.001, respectively), central hypointensity on arterial phase in NETs (p = 0.001), hepatobiliary target sign in ICCs (p = 0.002), the presence of septum and capsule in HCCs (all p < 0.001) were significant independent features of each tumor group over other tumor groups. Diagnostic accuracy for both observers was 98-98.6% for FNHs, 96.6-98% for HCAs, 97.3-98.6% for NETs, 90.5-94.6% for ICCs, and 85.8-93.2% for HCCs.

CONCLUSIONS: Ancillary MRI features established in our study can be helpful in the differentiation of hypervascular and hepatobiliary hypointense primary hepatic tumors on gadoxetic acid MRI.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Park HJ, Kim YK, Min JH, et al. Differentiation of hypervascular primary hepatic tumors showing hepatobiliary hypointensity on gadoxetic acid-enhanced magnetic resonance imaging. Abdom Radiol (NY). 2019. PMID: 31134313. doi:10.1007/s00261-019-02068-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。